Urokinase plasminogen activator and cathepsin D in micrometastatic cells of patients with primary breast cancer

被引：0
|
作者：
Solomayer, EF [1 ]
Diel, IJ [1 ]
Gollan, C [1 ]
Meyberg, G [1 ]
Bode, S [1 ]
Wallwiener, D [1 ]
Bastert, G [1 ]
机构：
[1] Univ Heidelberg, Dept OB GYN, D-69115 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89259-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P41
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [1] Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    Solomayer, EF
    Diel, IJ
    Wallwiener, D
    Bode, S
    Meyberg, G
    Sillem, M
    Gollan, O
    Kramer, MD
    Krainick, U
    Bastert, G
    BRITISH JOURNAL OF CANCER, 1997, 76 (06) : 812 - 818
  • [2] Prognostic relevance of urokinase plasminogen activator detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E-F Solomayer
    IJ Diel
    D Wallwiener
    S Bode
    G Meyberg
    M Sillem
    C Gollan
    MD Kramer
    U Krainick
    G Bastert
    British Journal of Cancer, 1997, 76 : 812 - 818
  • [3] Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients
    Chen, Qingyong
    Fei, Jun
    Wu, Lijun
    Jiang, Zhongyong
    Wu, Yuquan
    Zheng, Yun
    Lu, Guohua
    ONCOLOGY LETTERS, 2011, 2 (04) : 693 - 699
  • [4] Comparative prognostic value of cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma
    Gohring, UJ
    Scharl, A
    Thelen, U
    Ahr, A
    Crombach, G
    ANTICANCER RESEARCH, 1996, 16 (02) : 1011 - 1018
  • [5] Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    E-F. Solomayer
    I.J. Diel
    G.C. Meyberg
    Ch. Gollan
    S. Bode
    D. Wallwiener
    G. Bastert
    Breast Cancer Research and Treatment, 1998, 49 : 145 - 154
  • [6] Prognostic relevance of cathepsin D detection in micrometastatic cells in the bone marrow of patients with primary breast cancer
    Solomayer, EF
    Diel, IJ
    Meyberg, GC
    Gollan, C
    Bode, S
    Wallwiener, D
    Bastert, G
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (02) : 145 - 154
  • [7] Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist
    Ignar, DM
    Andrews, JL
    Witherspoon, SM
    Leray, JD
    Clay, WC
    Kilpatrick, K
    Onori, J
    Kost, T
    Emerson, DL
    CLINICAL & EXPERIMENTAL METASTASIS, 1998, 16 (01) : 9 - 20
  • [8] Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist
    Ignar D.M.
    Andrews J.L.
    Witherspoon S.M.
    Leray J.D.
    Clay W.C.
    Kilpatrick K.
    Onori J.
    Kost T.
    Emerson D.L.
    Clinical & Experimental Metastasis, 1998, 16 (1) : 9 - 20
  • [9] Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer
    Escot, C
    Zhao, Y
    Puech, C
    Rochefort, H
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 38 (02) : 217 - 226
  • [10] UROKINASE PLASMINOGEN-ACTIVATOR AND UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR IN BREAST-CANCER
    DUGGAN, C
    MAGUIRE, T
    MCDERMOTT, E
    OHIGGINS, N
    FENNELLY, JJ
    DUFFY, MJ
    INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) : 597 - 600
12345